ArticleCancers2022

Tyrosine Kinase Inhibitor Independent Gene Expression Signature in CML Offers New Targets for LSPC Eradication Therapy.

Eduardo Gómez-Castañeda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.